Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Prothrombotic state in children with obstructive sleep apnea.
Barceló A, Morell-Garcia D, Sanchís P, Peña-Zarza JA, Bauça JM, Piérola J, Peña M, Toledo-Pons N, Giménez P, Ribot C, Alonso-Fernández A.
Sleep Med. 2019 Jan;53:101-105. doi: 10.1016/j.sleep.2018.09.022. Epub 2018 Oct 13.
Similar articles
Xlr1 is involved in the transcriptional control of the pentose catabolic pathway, but not hemi-cellulolytic enzymes in Magnaporthe oryzae.
Battaglia E, Klaubauf S, Vallet J, Ribot C, Lebrun MH, de Vries RP.
Fungal Genet Biol. 2013 Aug;57:76-84. doi: 10.1016/j.fgb.2013.06.005. Epub 2013 Jun 27.
The rice resistance protein pair RGA4/RGA5 recognizes the Magnaporthe oryzae effectors AVR-Pia and AVR1-CO39 by direct binding.
Cesari S, Thilliez G, Ribot C, Chalvon V, Michel C, Jauneau A, Rivas S, Alaux L, Kanzaki H, Okuyama Y, Morel JB, Fournier E, Tharreau D, Terauchi R, Kroj T.
Plant Cell. 2013 Apr;25(4):1463-81. doi: 10.1105/tpc.112.107201. Epub 2013 Apr 2.
The pentose catabolic pathway of the rice-blast fungus Magnaporthe oryzae involves a novel pentose reductase restricted to few fungal species.
Klaubauf S, Ribot C, Melayah D, Lagorce A, Lebrun MH, de Vries RP.
FEBS Lett. 2013 May 2;587(9):1346-52. doi: 10.1016/j.febslet.2013.03.003. Epub 2013 Mar 13.
The Magnaporthe oryzae effector AVR1-CO39 is translocated into rice cells independently of a fungal-derived machinery.
Ribot C, Césari S, Abidi I, Chalvon V, Bournaud C, Vallet J, Lebrun MH, Morel JB, Kroj T.
Plant J. 2013 Apr;74(1):1-12. doi: 10.1111/tpj.12099. Epub 2013 Mar 4.
PHO1 expression in guard cells mediates the stomatal response to abscisic acid in Arabidopsis.
Zimmerli C, Ribot C, Vavasseur A, Bauer H, Hedrich R, Poirier Y.
Plant J. 2012 Oct;72(2):199-211. doi: 10.1111/j.1365-313X.2012.05058.x. Epub 2012 Aug 3.
The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling.
Seillet C, Laffont S, Trémollières F, Rouquié N, Ribot C, Arnal JF, Douin-Echinard V, Gourdy P, Guéry JC.
Blood. 2012 Jan 12;119(2):454-64. doi: 10.1182/blood-2011-08-371831. Epub 2011 Nov 16.
The tig1 histone deacetylase complex regulates infectious growth in the rice blast fungus Magnaporthe oryzae.
Ding SL, Liu W, Iliuk A, Ribot C, Vallet J, Tao A, Wang Y, Lebrun MH, Xu JR.
Plant Cell. 2010 Jul;22(7):2495-508. doi: 10.1105/tpc.110.074302. Epub 2010 Jul 30.
Fracture risk in early postmenopausal women assessed using FRAX.
Trémollieres F, Cochet T, Cohade C, Pouillès JM, Ribot C.
Joint Bone Spine. 2010 Jul;77(4):345-8. doi: 10.1016/j.jbspin.2010.04.012. Epub 2010 Jun 4.
Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA, Pouillès JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P.
J Bone Miner Res. 2010 May;25(5):1002-9. doi: 10.1002/jbmr.12.
Bone mineral density and prediction of non-osteoporotic disease.
Tremollieres F, Ribot C.
Maturitas. 2010 Apr;65(4):348-51. doi: 10.1016/j.maturitas.2009.12.023. Epub 2010 Jan 15. Review.
A single amino acid change (Y318F) in the L-arabitol dehydrogenase (LadA) from Aspergillus niger results in a significant increase in affinity for D-sorbitol.
Rutten L, Ribot C, Trejo-Aguilar B, Wösten HA, de Vries RP.
BMC Microbiol. 2009 Aug 12;9:166. doi: 10.1186/1471-2180-9-166.
[How to prevent early postmenopausal fracture risk? Proposition of a strategy].
Trémollieres F, Pouilles JM, Ribot C.
Gynecol Obstet Fertil. 2009 Jan;37(1):50-6. doi: 10.1016/j.gyobfe.2008.09.017. Epub 2008 Dec 24. French.
Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives.
Rolland Y, Abellan van Kan G, Bénétos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Trémollières F, Weryha G, Vellas B.
J Nutr Health Aging. 2008 May;12(5):335-46. Review.
Induction of the Arabidopsis PHO1;H10 gene by 12-oxo-phytodienoic acid but not jasmonic acid via a CORONATINE INSENSITIVE1-dependent pathway.
Ribot C, Zimmerli C, Farmer EE, Reymond P, Poirier Y.
Plant Physiol. 2008 Jun;147(2):696-706. doi: 10.1104/pp.108.119321. Epub 2008 Apr 23.
Bone mineral density at menopause does not predict breast cancer incidence.
Trémollieres FA, Pouillès JM, Laparra J, Ribot C.
Osteoporos Int. 2008 Oct;19(10):1497-504. doi: 10.1007/s00198-008-0596-0. Epub 2008 Mar 29.
Expression analyses of three members of the AtPHO1 family reveal differential interactions between signaling pathways involved in phosphate deficiency and the responses to auxin, cytokinin, and abscisic acid.
Ribot C, Wang Y, Poirier Y.
Planta. 2008 Apr;227(5):1025-36. Epub 2007 Dec 19.
Analysis of blazed diffractive optical elements formed with artificial dielectrics.
Ribot C, Lalanne P, Lee MS, Loiseaux B, Huignard JP.
J Opt Soc Am A Opt Image Sci Vis. 2007 Dec;24(12):3819-26.
Susceptibility of rice to the blast fungus, Magnaporthe grisea.
Ribot C, Hirsch J, Balzergue S, Tharreau D, Nottéghem JL, Lebrun MH, Morel JB.
J Plant Physiol. 2008 Jan;165(1):114-24. Epub 2007 Oct 1. Review.
Members of the PHO1 gene family show limited functional redundancy in phosphate transfer to the shoot, and are regulated by phosphate deficiency via distinct pathways.
Stefanovic A, Ribot C, Rouached H, Wang Y, Chong J, Belbahri L, Delessert S, Poirier Y.
Plant J. 2007 Jun;50(6):982-94. Epub 2007 Apr 25.
[Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
Ribot C, Trémollieres F.
Gynecol Obstet Fertil. 2007 May;35(5):388-97. Epub 2007 Mar 27. Review. French.
[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk].
Ribot C, Trémollières F.
Presse Med. 2006 Oct;35(10 Pt 2):1557-63. Review. French.
Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.
Menopause. 2006 May-Jun;13(3):387-96. Erratum in: Menopause. 2006 Sep-Oct;13(5):850. Ribot, Jean [corrected to Ribot, Claude].
[Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus].
Calzada-Nocaudie M, Chanson P, Conte-Devolx B, Delemer B, Estour B, Henry JF, Houillier P, Kraimps JL, Ribot C, Rohmer V, Tabarin A, Verges B, Vidal-Trecan G, Wemeau JL, Weryha G; Service dEndocrinologie.
Ann Endocrinol (Paris). 2006 Mar;67(1):7-12. French. No abstract available.
[Raloxifene in postmenopausal women].
Trémollières F, Ribot C.
Gynecol Obstet Fertil. 2006 Feb;34(2):147-53. Epub 2006 Feb 17. Review. French.
Aromatase and regulation of bone remodeling.
Ribot C, Trémollieres F, Pouillés JM.
Joint Bone Spine. 2006 Jan;73(1):37-42. Epub 2005 Aug 1. Review.
Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics.
Pouillès JM, Trémollieres FA, Ribot C.
Osteoporos Int. 2006 Feb;17(2):193-200. Epub 2005 Jul 15.
[Management of postmenopausal osteoporosis].
Ribot C, Trémollières F, Pouillès JM.
Rev Prat. 2005 Feb 28;55(4):393-400. Review. French.
Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.
Delmas PD, Marianowski L, Perez Ade C, Ribot C, Pornel B, Palacios S, Lopes P; Aerodiol Study Group.
Maturitas. 2004 Jun 15;48(2):85-96.
Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women.
Trémollieres FA, Bauvin E, Cigagna F, Pouillès JM, Cauneille C, Arnaud C, Ribot C.
Menopause. 2004 May-Jun;11(3):323-30.
Structure and expression profile of the Arabidopsis PHO1 gene family indicates a broad role in inorganic phosphate homeostasis.
Wang Y, Ribot C, Rezzonico E, Poirier Y.
Plant Physiol. 2004 May;135(1):400-11. Epub 2004 Apr 30.
Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.
Sambrook PN, Geusens P, Ribot C, Solimano JA, Ferrer-Barriendos J, Gaines K, Verbruggen N, Melton ME.
J Intern Med. 2004 Apr;255(4):503-11.
[Comparison of changes in biochemical markers of bone remodeling after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate. Gynécol Obstét Fertil 2003; 31 : 434-441].
Ribot C.
Gynecol Obstet Fertil. 2003 Dec;31(12):1079-80. French. No abstract available.
Iron-sulphur cluster assembly in plants: distinct NFU proteins in mitochondria and plastids from Arabidopsis thaliana.
Léon S, Touraine B, Ribot C, Briat JF, Lobréaux S.
Biochem J. 2003 May 1;371(Pt 3):823-30.
[Current therapeutic means].
Trémollières F, Pouillès JM, Ribot C.
Presse Med. 2002 Apr 20;31(15):699-703. French.
[Screening techniques].
Presse Med. 2002 Apr 20;31(15):694-8. French.
[Diagnostic value of classical neurophysiologic profile in various phenotypes of hereditary, pressure-sensitive neuropathies].
Drouet A, Guilloton L, Ribot C.
Rev Med Interne. 2002 Apr;23(4):364-71. French.
[Neuritic leprosy disclosed by reversal reaction].
Guilloton L, Drouet A, Combemale P, Cruel T, Dupin M, Ribot C.
Rev Neurol (Paris). 2002 Jan;158(1):84-6. French.
[Multiple intracranial and intraspinal meningiomas successively discovered in the absence of neurofibromatosis: 2 cases].
Drouet A, Guilloton L, Pelissou-Guyotat I, Saint-Pierre G, Ribot C, Sindou M, Deruty R.
Rev Neurol (Paris). 2001 Oct;157(10):1264-9. French.
[Muscular exercise intolerance syndrome in Becker muscular dystrophy].
Drouet A, Leturcq F, Guilloton L, Delage H, Ribot C.
Presse Med. 2002 Feb 9;31(5):197-201. French.
[Transformation of mycosis fungoides to pleomorphic T-cell lymphoma and central nervous system involvement].
Guilloton L, Drouet A, Estival JL, Saint Pierre G, Dupin M, Ribot C.
Rev Med Interne. 2001 Dec;22(12):1244-7. French.
Is absorptiometry useful for monitoring osteoporosis treatment?
Pouilles JM, Ribot C, Trémollières F.
Joint Bone Spine. 2001 Oct;68(5):367-9. No abstract available.
[Recurrent rhabdomyolysis revealing chronic exertional compartment syndrome of the biceps].
Drouet A, Guilloton L, Volckmann P, Ribot C, Flechaire A.
Ann Readapt Med Phys. 2001 Mar;44(2):95-8. French.
[Anterior compartment syndrome of the forearm caused by exercise: unusual cause of recurrent episodes of acute effort rhabdomyolysis].
Drouet A, Jaquin O, Guilloton L, Dumas P, Volckmann P, Ribot C.
Rev Med Interne. 2001 Apr;22(4):394-7. French.
Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
Trémollieres FA, Pouilles JM, Ribot C.
Osteoporos Int. 2001;12(5):385-90.
Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause.
Pouillès JM, Tremollières FA, Martinez S, Delsol M, Ribot C.
Osteoporos Int. 2001;12(1):71-6.
[Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].
Ribot C, Tremollieres F, Pouilles JM.
Ann Med Interne (Paris). 2000 Oct;151(6):490-6. Review. French.
Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
Tremollieres FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C.
Atherosclerosis. 2000 Nov;153(1):81-8.
[Mitochondrial diabetes complicated by or associated with "MELAS" syndrome?].
Drouet A, Guilloton L, Godinot C, Rochet D, Ribot C, Carrier H.
Rev Neurol (Paris). 2000 Oct;156(10):892-5. French.
Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.
Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY.
J Clin Endocrinol Metab. 2000 May;85(5):1895-900.
Filters: Manage Filters